🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and atrial fibrillation risk — November 2025 Page 5

GLP-1 and atrial fibrillation risk — November 2025

NurseLeah_Nash Fri, Jul 25, 2025 at 7:42 AM 39 replies 2,030 viewsPage 5 of 8
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Jul 25, 2025 at 2:47 PM#21

Just wanted to say — for anyone reading this GLP-1 and atrial thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jul 25, 2025 at 4:47 PM
22 9PharmD_Rodriguez, julia.endo, JessicaM_2024 and 19 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jul 25, 2025 at 3:04 PM#22

Want to share my personal experience related to GLP-1 and atrial fibrillation since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 286 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 18 months later: I am down 86 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The GLP-1 and atrial aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

3 11Dr.PathRoch, mona_PHX, andrew_nyc
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Jul 25, 2025 at 3:21 PM#23

Clinical perspective on GLP-1 and atrial fibrillation risk :

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

Last edited: Jul 25, 2025 at 6:21 PM
9 11marcus_mpls, DeniseRN_TPA, SandraNC_45 and 6 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Jul 25, 2025 at 3:38 PM#24

Thank you james_edin! This is incredibly helpful. Bookmarking for later. 🙏

11 0lori_vegas, Dr.PulmRoch, maya_sedona and 8 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Jul 25, 2025 at 3:55 PM#25

Relevant to GLP-1 and atrial fibrillation — here is my latest bloodwork comparison:

Key improvements: A1C 8.4% → 5.5%, triglycerides 249 → 119 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Jul 25, 2025 at 4:55 PM
45 20jason_sac26, chris_chi24, tampaLisa73 and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register